Clinical Trial Update: Possible New Therapy for Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating a new therapy for adrenocortical carcinoma conducted by INSYS Therapeutics Inc was terminated; no results are provided in the upda…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Snippet

Sponsor: INSYS Therapeutics Inc | Conditions: Adrenocortical Carcinoma | Phase 1 | Status: TERMINATED